Although the loss of CD26 in CD4 T cells is a hallmark of CTCL, our SS patients exhibited a decreased percentage of circulating CD8+CD26+ T cells. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.